Ignite Creation Date:
2024-05-06 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05730556
Status:
TERMINATED
Last Update Posted:
2024-04-09
First Post:
2023-02-06
Brief Title:
A Study of Remote Electrical Neuromodulation for Acute Procedural Pain
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
Remote Electrical Neuromodulation for Acute Procedural Pain in Chronic Migraine Patients Receiving onabotulinumtoxinA
Status:
TERMINATED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Enough data was collected to demonstrate device efficacy at interim analysis
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the effectiveness of using remote electrical neuromodulation using the Nerivio device to relieve pain associated with receiving onabotulinumtoxinA Botox injections for chronic migraine prevention
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None